Maternal Life History- Versus Gestation-Focused Assessment of Prenatal Exposure to Substances of Abuse

Journal of Substance Abuse

Volumn 11, Issue 4, 2000, Pages 355-368

  Goldstein, Risë B ^a,b   Mcavay, Gail J ^b   Nunes, Edward V ^c   Weissman, Myrna M ^c  

^a ROW Sciences Inc   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

ADULT; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; CIGARETTE SMOKING; FEMALE; HUMAN; MEDICAL RECORD; MOTHER; OPIATE ADDICTION; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SCHOOL CHILD; SMOKING; STATISTICAL ANALYSIS; SUBSTANCE ABUSE; ADDICTION; ADOLESCENT; CHILD; INTERPERSONAL COMMUNICATION; MALE; MENTAL DISEASE; PERSONALITY TEST; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MOTHERS; PERSONALITY ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS; TRUTH DISCLOSURE;

EID: 0034564902     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(00)00032-8     Document Type: Article

References (34)

1. Agresti A. Categorical Data Analysis. 1990;Wiley, New York.
2. Diagnostic and Statistical Manual of Mental Disorders. 3rd edn. 1987;American Psychiatric Press, Washington, DC. revised.
3. Belcher H.M., Shapiro B.K., Leppert M., Butz A.M., Sellers S., Arch E., Kolodner K., Pulsifer M., Lears M.K., Kaufmann W.E. Sequential neuromotor examination in children with intrauterine cocaine/polydrug exposure. Dev Med Child Neurol. 41:1999;240-246.
4. Chavkin W. Drug addiction and pregnancy: Policy crossroads. Am J Public Health. 80:1990;483-487.
5. Chavkin W. Mandatory treatment for drug use during pregnancy. JAMA. 266:1991;1556-1561.
6. Coles C.D. Discussion: Measurement issues in the study of effects of substance abuse in pregnancy. Kilbey M.M., Asghar K. Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug-Exposed Women and their Children (NIDA Research Monograph 117). 1992;U.S. Government Printing Office, Washington, DC.
7. Dow-Edwards D. The puzzle of cocaine's effects following maternal use during pregnancy: Still unsolved. Neurotoxicol Teratol. 15:1993;295-296.
8. Endicott J., Spitzer R.L. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 35:1978;773-782.
9. Ernhart C.B., Morrow-Tlucak M., Sokol R.J., Martier S. Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res. 12:1988;506-511.
10. Fergusson D.M., Woodward L.J., Horwood L.J. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Arch Gen Psychiatry. 55:1998;721-727.
11. Fleiss J.L. Statistical Methods for Rates and Proportions. 1981;Wiley, New York.
12. Frank D.A., Zuckerman B.S. Children exposed to cocaine prenatally: Pieces of the puzzle. Neurotoxicol Teratol. 15:1993;298-300.
13. Garcia S.A. Maternal drug abuse: Laws and ethics as agents of just balances and therapeutic interventions. Int J Addict. 28:1993;1311-1339.
14. Howard Jet al. Subject recruitment and retention issues in longitudinal research involving substance-abusing families: A clinical services context. Kilbey M.M., Asghar K. Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug-Exposed Women and their Children (NIDA Research Monograph 117). 1992;U.S. Government Printing Office, Washington, DC.
15. Jacobson S.W., Jacobson J.L., Sokol R.J., Martier S.S., Ager J.W., Kaplan M.G. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol. 13:1991;535-540.
16. Kelsey J.L., Whittemore A.S., Evans A.E., Thompson W.D. Methods in Observational Epidemiology. 1996;Oxford Univ. Press, New York.
17. Kline J., Stein Z., Susser M. Conception to Birth: The Epidemiology of Prenatal Development. 1989;Oxford Univ. Press, New York.
18. Koren G., Nulman I., Rovet J., Greenbaum R., Loebstein M., Einarson T. Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto adoption study. Ann N Y Acad Sci. 846:1998;306-313.
19. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimates of lifetime psychiatric diagnosis: A methodologic study. Arch Gen Psychiatry. 39:1982;879-883.
20. Magura S., Goldsmith D., Casriel C., Goldstein P.J., Lipton D.S. The validity of methadone clients' self-reported drug use. Int J Addict. 22:1987;727-749.
21. Mieczkowski T., Barzelay D., Gropper B., Wish E. Concordance of three measures of cocaine use in an arrestee population: Hair, urine, and self-report. J Psychoact Drugs. 23:1991;241-249.
22. Neuspiel D.R. Cocaine and the fetus: Mythology of severe risk. Neurotoxicol Teratol. 15:1993;305-306.
23. Nunes E.V., Weissman M.M., Goldstein R.B., McAvay G., Seracini A.M., Verdeli H., Wickramaratne P. Psychopathology in children of parents with opiate dependence and/or major depression. J Am Acad Child Adolesc Psychiatry. 37:1998;1142-1151.
24. Orvaschel H., Puig-Antich J., Chambers W., Tabrizi M.A., Johnson R. Retrospective assessment of prepubertal major depression with the Kiddie-SADS-E. J Am Acad Child Adolesc Psychiatry. 21:1982;392-397.
25. Ostrea E.M. Jr. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. Kilbey M.M., Asghar K. Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug-Exposed Women and their Children (NIDA Research Monograph 117). 1992;U.S. Government Printing Office, Washington, DC.
26. Page W.F., Davies J.E., Ladner R.A., Alfassa J. Urinalysis screened vs. verbally reported drug use: The identification of discrepant groups. Int J Addict. 12:1977;439-450.
27. Sagatun-Edwards I.J., Saylor C., Shifflett B. Drug exposed infants in the social welfare system and juvenile court. Child Abuse Neglect. 19:1995;83-91.
28. SAS/STAT Software: Changes and Enhancements Through Release 6.11. 1996;SAS Institute, Cary, NC.
29. Sherwood R.A., Keating J., Kavvadia V., Greenough A., Peters T.J. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr. 158:1999;488-492.
30. Sokol R.J., Ager J.W., Martier S.S. Methodological issues in obtaining and managing substance abuse information from prenatal patients. Kilbey M.M., Asghar K. Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug-Exposed Women and their Children (NIDA Research Monograph 117). 1992;U.S. Government Printing Office, Washington, DC.
31. Steinbock B. The relevance of illegality. Hastings Center Rep. 22:1992;19-22.
32. Streissguth A.P., Barr H.M., Sampson P.D., Bookstein F.L. Prenatal alcohol and offspring development: The first fourteen years. Drug Alcohol Depend. 36:1994;89-99.
33. Weissman M.M., Merikangas K.R., John K., Wickramaratne P.J., Prusoff B.A., Kidd K.K. Family-genetic studies of psychiatric disorders: Developing technologies. Arch Gen Psychiatry. 43:1986;1104-1116.
34. Weissman M.M., Warner V., Wickramaratne P.J., Kandel D.B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry. 38:1999;892-899.